Apyx Medical Corporation (APYX)
NASDAQ: APYX · IEX Real-Time Price · USD
1.260
-0.060 (-4.55%)
Apr 22, 2024, 4:00 PM EDT - Market closed
Apyx Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 52.35 | 44.51 | 48.52 | 27.71 | 28.24 | 16.61 | 10.23 | 8.82 | 29.52 | 27.68 | Upgrade
|
| Revenue Growth (YoY) | 17.61% | -8.26% | 75.08% | -1.86% | 70.04% | 62.25% | 16.04% | -70.13% | 6.64% | 16.99% | Upgrade
|
| Cost of Revenue | 18.59 | 15.38 | 14.92 | 10.21 | 9.14 | 5.78 | 3.28 | 3.7 | 16.96 | 18.69 | Upgrade
|
| Gross Profit | 33.76 | 29.13 | 33.6 | 17.5 | 19.09 | 10.83 | 6.96 | 5.12 | 12.56 | 8.99 | Upgrade
|
| Selling, General & Admin | 48.87 | 48.15 | 43.73 | 33.67 | 36.23 | 21.81 | 17.38 | 15.48 | 17.38 | 13.43 | Upgrade
|
| Research & Development | 4.84 | 4.54 | 4.32 | 3.92 | 3.73 | 2.55 | 1.94 | 1.03 | 2.16 | 1.42 | Upgrade
|
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0.74 | 1.52 | 0 | 0 | 0 | Upgrade
|
| Operating Expenses | 53.71 | 52.69 | 48.05 | 37.59 | 39.96 | 25.1 | 20.84 | 16.51 | 19.54 | 14.84 | Upgrade
|
| Operating Income | -19.95 | -23.56 | -14.45 | -20.08 | -20.87 | -14.28 | -13.89 | -11.39 | -6.99 | -5.85 | Upgrade
|
| Interest Expense / Income | 2.48 | 0.02 | 0.01 | 0.05 | 0.01 | 0.1 | 0.14 | 0.16 | 0.16 | 0.15 | Upgrade
|
| Other Expense / Income | -1.28 | -0.76 | 0.33 | -0.73 | -1.04 | -73.19 | -8.8 | -7.66 | -15.76 | 7.29 | Upgrade
|
| Pretax Income | -21.15 | -22.82 | -14.79 | -19.4 | -19.84 | 58.81 | -5.22 | -3.89 | 8.61 | -13.29 | Upgrade
|
| Income Tax | -2.43 | 0.37 | 0.38 | -7.5 | -0.13 | -3.91 | -0.16 | 0.06 | 0.03 | 4 | Upgrade
|
| Net Income | -18.71 | -23.18 | -15.17 | -11.9 | -19.71 | 62.72 | -5.06 | -3.95 | 8.59 | -17.28 | Upgrade
|
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.22 | 0.93 | Upgrade
|
| Net Income Common | -18.71 | -23.18 | -15.17 | -11.9 | -19.71 | 62.72 | -5.06 | -3.95 | 8.36 | -18.21 | Upgrade
|
| Shares Outstanding (Basic) | 35 | 35 | 34 | 34 | 34 | 33 | 31 | 27 | 24 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 35 | 35 | 34 | 34 | 34 | 34 | 31 | 27 | 28 | 18 | Upgrade
|
| Shares Change | 0.31% | 0.54% | 0.35% | 0.42% | -0.86% | 9.35% | 14.49% | -1.07% | 56.27% | 0.49% | Upgrade
|
| EPS (Basic) | -0.54 | -0.67 | -0.44 | -0.35 | -0.58 | 1.89 | -0.16 | -0.15 | 0.34 | -1.03 | Upgrade
|
| EPS (Diluted) | -0.54 | -0.67 | -0.44 | -0.35 | -0.58 | 1.83 | -0.17 | -0.14 | 0.24 | -1.03 | Upgrade
|
| Free Cash Flow | 1.49 | -21.29 | -11.17 | -16.65 | -19.78 | -21.24 | -4.33 | -3.12 | -6.21 | -1.05 | Upgrade
|
| Free Cash Flow Per Share | 0.04 | -0.62 | -0.33 | -0.49 | -0.58 | -0.64 | -0.14 | -0.11 | -0.26 | -0.06 | Upgrade
|
| Gross Margin | 64.49% | 65.45% | 69.26% | 63.17% | 67.63% | 65.20% | 67.99% | 58.01% | 42.54% | 32.48% | Upgrade
|
| Operating Margin | -38.11% | -52.94% | -29.78% | -72.47% | -73.91% | -85.97% | -135.68% | -129.18% | -23.67% | -21.13% | Upgrade
|
| Profit Margin | -35.75% | -52.09% | -31.27% | -42.93% | -69.79% | 377.71% | -49.46% | -44.79% | 28.33% | -65.80% | Upgrade
|
| Free Cash Flow Margin | 2.84% | -47.83% | -23.03% | -60.07% | -70.04% | -127.94% | -42.29% | -35.41% | -21.03% | -3.78% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | -6.64% | - | - | 0.29% | - | Upgrade
|
| EBITDA | -17.89 | -21.91 | -13.88 | -18.47 | -19.07 | 59.59 | -4.39 | -2.99 | 9.58 | -12.26 | Upgrade
|
| EBITDA Margin | -34.17% | -49.23% | -28.61% | -66.64% | -67.55% | 358.84% | -42.86% | -33.95% | 32.46% | -44.28% | Upgrade
|
| Depreciation & Amortization | 0.78 | 0.89 | 0.9 | 0.89 | 0.75 | 0.67 | 0.7 | 0.73 | 0.81 | 0.88 | Upgrade
|
| EBIT | -18.67 | -22.8 | -14.78 | -19.35 | -19.83 | 58.92 | -5.08 | -3.73 | 8.77 | -13.13 | Upgrade
|
| EBIT Margin | -35.66% | -51.23% | -30.47% | -69.84% | -70.22% | 354.81% | -49.66% | -42.27% | 29.71% | -47.45% | Upgrade
|